Drug Information Association Inc
DRUG INFORMATION ASSOCIATION, INC. ("DIA") FOSTERS INNOVATION TO IMPROVE HEALTH AND WELLBEING WORLDWIDE BY: - PROVIDING INVALUABLE FORUMS TO EXCHANGE VITAL INFORMATION AND DISCUSS CURRENT ISSUES RELATED TO HEALTH PRODUCTS, TECHNOLOGIES, AND SERVICES; - DELIVERING CUSTOMIZED LEARNING EXPERIENCES;- BUILDING, MAINTAINING, AND FACILITATING TRUSTED RELATIONSHIPS WITH AND AMONG INDIVIDUALS AND ORGANIZATIONS THAT DRIVE AND SHARE DIA VALUES AND MANDATES; AND - OFFERING A MULTIDISCIPLINARY NEUTRAL ENVIRONMENT, RESPECTED GLOBALLY FOR INTEGRITY AND RELEVANCY.
Financial Overview
From 2024 IRS Form 990-PF
Total Assets
$22.6M
-4.6% YoY
Annual Giving
—
Grant Count
0
Avg Grant Size
—
Go deeper than public filings
PRO- Giving trend analysis — growing or declining?
- Organizations like yours that won grants here
- Strategic fit assessment for your organization
- Application timing recommendations
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $22,590,311 | $23,691,852 | $24,485,219 |
| Revenue | $19,971,897 | $21,940,328 | $19,858,774 |
| Expenses | $22,058,438 | $23,019,356 | $22,321,024 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $586,383 | $377,131 | $1,309,073 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 0 recipients in 2024
Grant Size Distribution
1 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for .
Who else does Drug Information Association Inc fund?
Explore the funder–grantee relationships behind this foundation, powered by GrantGraph™ — our database of 11 million+ funding connections.
- Similar orgs that won grants here
- GrantGraph™ relationship mapping
- 11M+ connections in GrantGraph™
Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| MARWAN FATHALLAH | PRESIDENT & CHIEF EXECUTIVE OFFICER | 40 | $986,809 |
| KIHITO TAKAHASHI | CHAIR | 2.5 | — |
| MICHAEL ROSENBLATT | IMMEDIATE PAST CHAIR | 2.5 | — |
| CYNTHIA VERST | IMMEDIATE PAST CHAIR (UNTIL 06/24) | 2.5 | — |
| TATYANA KOSHELEVA | TREASURER/SECRETARY | 2.5 | — |
| CHOCKALINGAM PALANIAPPAN | DIRECTOR | 1.25 | — |
| JASON MONTELEONE | DIRECTOR | 1.25 | — |
| JUNAID BAJWA | DIRECTOR | 1.25 | — |
| PETER HONIG | DIRECTOR | 1.25 | — |
| PETER RONCO | DIRECTOR | 1.25 | — |
| PETER SORGER | DIRECTOR | 1.25 | — |
| ZILI LI | DIRECTOR | 1.25 | — |
| DAVID MUKANGA | DIRECTOR | 1.25 | — |
| RACHEL ZHANG | DIRECTOR/INCOMING CHAIR | 1.25 | — |
| FRANK JIANG | DIRECTOR (UNTIL 06/24) | 1.25 | — |
| JENS GRUEGER | DIRECTOR (UNTIL 06/24) | 1.25 | — |
| JACK FOSTER | CHIEF FINANCIAL OFFICER | 40 | $380,306 |
| ANNA MCDERMOTT-VITAK | SVP/MNGING DIR AMER (UNTIL 7/24) | 40 | $241,447 |
| ANIA MITAN | SVP/MD, EMEAIS | 40 | $392,269 |
| CARIE PIERCE | SVP, GROWTH | 40 | $331,219 |
| TIM HESS | GLOBAL HEAD OF BUSINESS & DIGITAL TECH. | 40 | $289,456 |
| KATIE HILL | SVP/MD, GLOBAL PRODUCTS & PROF. EDUCATION | 40 | $267,391 |
| KATIE TRUONG | SVP/MD, AMERICAS & GLOBAL HEAD OF BUSINESS OPS. | 40 | $251,260 |
| MARIA VASSILEVA | CHIEF SCIENCE & REGULATORY OFFICER | 40 | $167,622 |
| WELLINGTON CARRANZA | DIRECTOR, PMO & BUSINESS EXCELLENCE | 40 | $205,422 |
| GREG SMITH | SENIOR DIRECTOR, FINANCE & ACCOUNTING | 40 | $204,706 |
| JENNIFER ANDREE-WEBB | DIRECTOR, LEARNING & CONTINUING EDUCATION | 40 | $180,936 |
| LINDA HEE JUNG KO | ASSOC. DIR., BUSINESS DEV. | 40 | $177,563 |
| PEDRO BARROCA | ASSOC. DIR., OPERATIONS TRANSFORMATION | 40 | $168,804 |
Geographic Focus
Where this funder has awarded grants
Grant Distribution by State
States
Cities
Data last updated March 2026. Sourced from IRS Form 990-PF filings.
What could you do with Drug Information Association Inc on Grantable?
- Assess strategic fit with your organization
- Get AI-generated opportunity briefs
- Monitor for new funding opportunities
- Draft a tailored letter of inquiry